-+ 0.00%
-+ 0.00%
-+ 0.00%

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga·08/20/2025 12:08:41
Listen to the news

Gainers

  • NovaBay Pharmaceuticals (AMEX:NBY) stock rose 59.9% to $0.96 during Wednesday's pre-market session. The market value of their outstanding shares is at $3.4 million. As per the press release, Q2 earnings came out 4 days ago.
  • Tharimmune (NASDAQ:THAR) shares increased by 47.0% to $1.72. The market value of their outstanding shares is at $6.1 million. The company's, Q2 earnings came out 4 days ago.
  • Propanc Biopharma (NASDAQ:PPCB) shares rose 32.69% to $4.87. The company's market cap stands at $42.6 million.
  • Rocket Pharmaceuticals (NASDAQ:RCKT) stock moved upwards by 25.42% to $3.65. The market value of their outstanding shares is at $314.0 million.
  • Clene (NASDAQ:CLNN) shares rose 11.56% to $5.0. The market value of their outstanding shares is at $44.7 million. The company's, Q2 earnings came out 4 days ago.
  • CARISMA Therapeutics (NASDAQ:CARM) shares moved upwards by 9.24% to $0.26. The company's market cap stands at $9.9 million.

Losers

  • enVVeno Medical (NASDAQ:NVNO) shares fell 70.4% to $1.24 during Wednesday's pre-market session. The company's market cap stands at $73.4 million.
  • PainReform (NASDAQ:PRFX) shares decreased by 24.9% to $1.78. The company's market cap stands at $4.4 million.
  • CytoSorbents (NASDAQ:CTSO) stock fell 23.15% to $0.83. The company's market cap stands at $67.7 million.
  • Calidi Biotherapeutics (AMEX:CLDI) stock decreased by 16.67% to $2.5. The market value of their outstanding shares is at $10.2 million.
  • Celldex Therapeutics (NASDAQ:CLDX) stock decreased by 11.12% to $21.35. The market value of their outstanding shares is at $1.5 billion.
  • Alcon (NYSE:ALC) shares declined by 10.69% to $80.49. The company's market cap stands at $44.5 billion. As per the news, the Q2 earnings report came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.